Investing Profile

Roberto De Ponti

InvestorVC
Managing Director and General Partner at 3B FUTURE Health
Photo of Roberto De Ponti, Managing Director at 3B Future Health Ventures (Helsinn Investment Fund)
cb
$100K - $5.0M
$1.5M
4
$12M
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DAug 2023$75M
$130M
Co-investors: Michal Silverberg (Novartis Venture Fund), Matthew Foy (SR One), Chandra Leo (Hbm Partners), Ran Nussbaum (Pontifax Venture Capital)
Geneos Therapeutics
Series AApr 2023$5M
$17M
Co-investors: Sangwoo Lee (Korea Investment Partners)
Roca Therapeutics
SeedSep 2022
Domain Therapeutics
Series AMay 2022$41M
$47M
Co-investors: Emmanuel Fiessinger (Seventure Partners)